Yang-jia Zhuo

Guangdong Key Laboratory Of Clinical Molecular
Guangzhou, 510180, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 18 publications

Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Retraction Note: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Journal: Molecular cancer

Published: March 21, 2023

Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer.

Tumor Suppressor Role and Clinical Significance of the FEV Gene in Prostate Cancer.

Journal: Disease markers

Published: May 06, 2021

Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma.

Novel immune-related signature for risk stratification and prognosis in prostatic adenocarcinoma.

Journal: Cancer science

Published: February 06, 2021

Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Correction to: MicroRNA-30d promotes angiogenesis and tumor growth via MYPT1/c-JUN/VEGFA pathway and predicts aggressive outcome in prostate cancer.

Journal: Molecular cancer

Published: August 08, 2019

miR‑505 suppresses prostate cancer progression by targeting NRCAM.

miR‑505 suppresses prostate cancer progression by targeting NRCAM.

Journal: Oncology reports

Published: February 17, 2019

[Corrigendum] miR‑505 suppresses prostate cancer progression by targeting NRCAM.

[Corrigendum] miR‑505 suppresses prostate cancer progression by targeting NRCAM.

Journal: Oncology reports

Published: February 17, 2019

HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer.

HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer.

Journal: Pathology, research and practice

Published: January 01, 2019

TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer.

TRIB1 induces macrophages to M2 phenotype by inhibiting IKB-zeta in prostate cancer.

Journal: Cellular signalling

Published: January 01, 2019

Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.

Downregulation of ARID4A and ARID4B promote tumor progression and directly regulated by microRNA-30d in patient with prostate cancer.

Journal: Journal of cellular biochemistry

Published: October 22, 2017

Mechanism of pingyangmycin-induced apoptosis of cultured human umbilical vein endothelial cells.

Mechanism of pingyangmycin-induced apoptosis of cultured human umbilical vein endothelial cells.

Journal: Genetics and molecular research : GMR

Published: May 17, 2017

Role of GPR30 in estrogen-induced prostate epithelial apoptosis and benign prostatic hyperplasia.

Role of GPR30 in estrogen-induced prostate epithelial apoptosis and benign prostatic hyperplasia.

Journal: Biochemical and biophysical research communications

Published: April 02, 2017

High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.

High expression of ASPM correlates with tumor progression and predicts poor outcome in patients with prostate cancer.

Journal: International urology and nephrology

Published: December 04, 2016

Showing 1-12 of 18

Last Updated: 09/26/2026